Full Text (PDF)
Short Communication

Use of Ocular Biomarkers for Predicting Systemic Bone Health in Orthopaedic Patients

Jeff Walter Rajadurai OR, Radhika Dinesh, S. Jeeva

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Orthopedic Education 11(2):p 65-68, May. Aug 2025. | DOI: 10.21088/joe.2454a.7956.11225.5

How Cite This Article:

Rajadurai JW, Radhika D, Jeeva S. Use of Ocular Biomarkers for Predicting Systemic Bone Health in Orthopaedic Patients. Jr Orth Edu. 2025;11(2):65-8.

Timeline

Received : March 21, 2025         Accepted : June 03, 2025          Published : August 30, 2025

Abstract

Using signs from the eye to understand what’s going on in the bones might sound unusual at first but it’s a line of thought that’s slowly gaining momentum. After all, a number of systemic diseases show up in the eye, and doctors have long relied on this connection. So, it’s not a big leap to consider whether eye health could also reflect bone health, especially in conditions like osteoporosis. In this work, we take a closer look at whether certain patterns things like how blood vessels look at the back of the eye, how stiff the cornea is, or changes around the optic disc might offer early clues about bone weakness. It’s not just guesswork; some of these features seem to share the same underlying causes as bone deterioration: inflammation, tiny vessel problems, and oxidative stress, to name a few. With tools like OCT and new ways to map the retinal vessels, clinicians might be able to pick up these signs well before bone loss becomes obvious. For orthopaedic doctors, that could mean acting earlier, perhaps even adjusting care plans based on what’s seen in the eye. And maybe just maybe this could shift the focus a bit. From reacting to fractures to trying to prevent them. That’s the bigger picture. Of course, a lot more research is needed. But the potential is there, and it’s worth paying attention to.


References

  • 1.   Spaide R.F., Klancnik J.M., Cooney M.J. Retinal vascular imaging using optical coherence tomography angiography. Retina. 2015; 35(11): 2181-6. Jeff Walter Rajadurai OR, Radhika Dinesh, S. Jeeva. Use of Ocular Biomarkers for Predicting Systemic Bone Health in Orthopaedic Patients68 Journal of Orthopedic Education JOE/Volume 11 Number 2, May-August 2025
  • 2.   Cheung C.Y., Ikram M.K., Sabanayagam C., Wong T.Y. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension. 2012; 60(5): 1094-103.
  • 3.   Wells A.P., Garway-Heath D.F., Poostchi A., Wong T., Gazzard G., Foster P.J. Corneal hysteresis as a risk factor for glaucoma progression: a prospective study. Ophthalmology. 2008; 115(9): 1501-5.
  • 4.   Frost S.A., Nguyen N.D., Center J.R., Eisman J.A., Nguyen T.V. Risk factors for hip fracture in men aged 50 years and older: a prospective study. Bone. 2013; 52(1): 419-26.
  • 5.   Bourne R.R., Stevens G.A., White R.A., et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health. 2013; 1(6): e339-49.
  • 6.   Phipps J.A., Yaganti S., Schlotzer-Schrehardt U, et al. Proteomic markers of exfoliation syndrome support a chronic stress response in the trabecular meshwork. Exp Eye Res. 2012; 101: 27-34.
  • 7.   Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115(12): 3318-25.
  • 8.   Keenan T.D., Goldacre R., Goldacre M.J. Associations between primary open angle glaucoma, Alzheimer’s disease and vascular comorbidities: record linkage study. Br J Ophthalmol. 2015; 99(5): 665-8.
  • 9.   Schuman J.S., Hee M.R., Puliafito C.A., et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995; 113(5): 586-96.
  • 10.   Gulshan V., Peng L., Coram M., et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016; 316(22): 2402-10.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest.


About this article


Cite this article

Rajadurai JW, Radhika D, Jeeva S. Use of Ocular Biomarkers for Predicting Systemic Bone Health in Orthopaedic Patients. Jr Orth Edu. 2025;11(2):65-8.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
March 21, 2025 June 03, 2025 August 30, 2025

DOI: 10.21088/joe.2454a.7956.11225.5

Keywords

BiomarkersOsteoporosisOptical Coherence TomographyRetinal MicrovasculatureCorneal Biomechanics

Article Level Metrics

Last Updated

Sunday 21 June 2026, 18:11:10 (IST)


642

Accesses

7
126
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 21, 2025
Accepted June 03, 2025
Published August 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share